Abstract
The goal of this Special Issue is to highlight the ever-increasing progress in pharmacological research on sodium-glucose co-transporter (SGLT) type 2 (SGLT2) inhibitors or gliflozins [...].
MeSH terms
-
Diabetes Mellitus, Type 2* / drug therapy
-
Glucose
-
Humans
-
Hypoglycemic Agents / pharmacology
-
Sodium
-
Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
-
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
Substances
-
Sodium-Glucose Transporter 2 Inhibitors
-
Hypoglycemic Agents
-
Sodium
-
Glucose